company

NOVA-CURE AS

2317 HAMAR

Return on Equity
2 983,78 %
Current Ratio
0,97
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue3 424 000
Net Income1 104 000
Total Assets1 633 000
Total Equity37 000
Income (NOK)2022
Revenue3 424 000
Expenditure2 048 000
Operating Profit1 376 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax1 376 000
Tax271 000
Net Income1 104 000
Balance (NOK)2022
Total Fixed Assets78 000
Total Current Assets1 555 000
Total Assets1 633 000
Total Retained Equity7 000
Total Equity37 000
Total Long-Term Debt0
Total Current Debt1 595 000
Total Equity and Debt1 633 000
Cash flow (NOK)2022
Sales Income2 917 000
Other Income507 000
Revenue3 424 000
Cost of Goods Sold0
Salary Costs1 039 000
Depreciation0
Impairment0
Expenditure2 048 000
Operating Profit1 376 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends1 120 000
Net Income1 104 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures18 000
Total Tangible Assets18 000
Total Fiancial Fixed Assets60 000
Total Fixed Assets78 000
Stock0
Total Investments0
Cash, Bank1 555 000
Total Current Assets1 555 000
Total Assets1 633 000
Total Equity37 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes67 000
Dividends1 120 000
Other Current Debt137 000
Total Current Debt1 595 000
Total Equity and Debt1 633 000
Financial indicators2022
Return on Equity2 983,78 %
Debt-to-Equity Ratio0
Operating Profit Margin40,19 %
Current Ratio0,97
Quick Ratio0,97
Equity Ratio0,02
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English